Payment completion of treasury stock for employee stock-based compensation and performance-based restricted stock compensation. The number of disposed shares is approximate, allocated to internal directors. A separate document discloses payment date, share count, and price.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4528","jir_company_name":"Ono Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-07-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/4528-20260710-01.pdf","jir_short_summary":"Payment completion of treasury stock for employee stock-based compensation and performance-based restricted stock compensation. The number of disposed shares is approximate, allocated to internal directors. A separate document discloses payment date, share count, and price.","jir_summary":"### Overview\nToday, as of July 10, 2026, payment procedures for the disposition of treasury stock as part of employee stock-based compensation and performance-based restricted stock compensation based on the board of directors\u2019 resolution on June 18, 2026, have been completed. Payment date is the same day. The disposals are potentially to total over 270,000 shares, allocated to three internal directors and 12\u201313 executive officers who do not concurrently serve as directors, though the breakdown of executives is included in the text.\n\n### Impact and Outlook\nThe disposal of treasury stock is conducted as part of the remuneration system, and its impact on shareholder value depends on the number of disposed shares and price per share. The disposal price is 2,249.5 yen per share, and the total amount is referenced in related materials. The move appears aimed at enhancing transparency of internal compensation systems and strengthening human incentives. Future disclosure trends and assessments of impact on shareholders will require reference to the detailed materials already issued.","jir_financial_highlights":"Total disposal amount: Unknown (Unknown)\nDisposal shares for employee stock-based compensation: 20,900 shares (Unknown)\nDisposal shares for performance-based restricted stock compensation: 273,500 shares (Unknown)","jir_category":"","jir_hashtags":"#Ono Pharmaceutical Co., Ltd., #stock_option, #IR","jir_key_figures":"Disposal shares (employee stock-based compensation): 20,900 shares\nDisposal shares (performance-based compensation): 179,000 shares\nDisposal price: 2,249.5 yen per share","jir_meta_title":"Ono Pharmaceutical Co., Ltd. Notice of Completion of Treasury Stock Disposition Payment | July 2026","jir_meta_description":"OnO Pharmaceutical announces the completion of payment for treasury stock disposition as part of employee stock-based and performance-based restricted stock compensation. Details on disposed shares and price. Explains impact on shareholder value and future trends.","jir_og_title":"OnO Pharmaceutical: Payment Completion of Treasury Stock Disposition Announced | July 2026","jir_og_description":"OnO Pharmaceutical announces the payment completion for treasury stock disposition. Provides details on restricted stock compensation for both employee stock-based and performance-based schemes.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7530,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-77906","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n